Welcia (3141) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Jun, 2025Executive summary
Net sales for FY2025 3Q reached 951,916 million yen, up 4.6% year-over-year, driven by dispensing sales and M&A activity.
Operating income decreased 26.5% year-over-year to 22,856 million yen due to higher SG&A from aggressive HR investment.
Net income attributable to owners of parent was 14,778 million yen, down 27.5% year-over-year.
Store network expanded to 3,014 locations, including new subsidiaries Welpark and WELCIA PARTNERS, with a focus on PB product development and customer engagement.
Discontinued cigarette sales and launched health-focused initiatives as part of the 2030 vision.
Financial highlights
Gross operating profit for 3Q was 284,964 million yen, up 3.7% year-over-year.
SG&A expenses rose 7.6% year-over-year to 262,108 million yen, mainly from labor and advertising costs.
Ordinary income decreased 23.2% year-over-year to 26,352 million yen.
Net income per share was 71.41 yen, down from 98.44 yen in the prior year period.
Comprehensive income fell 30.2% year-over-year to 14,335 million yen.
Outlook and guidance
Full-year net sales forecast revised to 1,295,000 million yen, up 6.4% year-over-year.
Full-year operating income forecast at 34,000 million yen, 78.6% of the previous year.
Net income attributable to owners of parent projected at 19,000 million yen, 71.8% of the previous year.
Annual dividend forecast raised to 36.00 yen per share, up from 34.00 yen in the previous year.
Latest events from Welcia
- Strong profit and sales growth driven by M&A, dispensing, and private brand expansion.3141
Q2 20268 Oct 2025 - Profit and sales soared, driven by M&A, dispensing, and food sales growth.3141
Q1 20268 Jul 2025 - Sales up, profits down as higher costs and competition offset dispensing growth.3141
Q2 202513 Jun 2025 - Sales up 2.2%, net income down 44.9%; outlook steady, dividend to rise.3141
Q1 202513 Jun 2025 - Integration forms Japan's top drugstore group, aiming for 3 trillion yen sales by FY2032.3141
Q4 20256 Jun 2025